APX-115
CAS No. 1395946-75-4
APX-115( Ewha 18278 | APX 115 | APX115 )
Catalog No. M11653 CAS No. 1395946-75-4
APX-115 (Ewha 18278)?is a first-in-class, orally active, pan-NADPH oxidase (Nox) inhibitor with Ki of 1.08, 0.57, 0.63 nM for Nox1, Nox2, and Nox4, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 110 | Get Quote |
|
| 10MG | 177 | Get Quote |
|
| 25MG | 372 | Get Quote |
|
| 50MG | 556 | Get Quote |
|
| 100MG | 791 | Get Quote |
|
| 500MG | 1611 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAPX-115
-
NoteResearch use only, not for human use.
-
Brief DescriptionAPX-115 (Ewha 18278)?is a first-in-class, orally active, pan-NADPH oxidase (Nox) inhibitor with Ki of 1.08, 0.57, 0.63 nM for Nox1, Nox2, and Nox4, respectively.
-
DescriptionAPX-115 (Ewha 18278)?is a first-in-class, orally active, pan-NADPH oxidase (Nox) inhibitor with Ki of 1.08, 0.57, 0.63 nM for Nox1, Nox2, and Nox4, respectively; shows no inhibitory activities on xanthine oxidase and glucose oxidase; inhibits the responses of BMMs to RANKL, including ROS generation, activation of MAPK and NF-κB, and osteoclast cells differentiation; protects db/db mice from renal injury.Diabetes Preclinical.
-
In Vitro——
-
In VivoAnimal Model:Six-week-old male diabetic db/db mice (C57BLKS/J-leprdb/leprdb)Dosage:60?mg/kg Administration:Oral gavage; per day; for 12 weeks Result:Significantly improved insulin resistance in diabetic mice.
-
SynonymsEwha 18278 | APX 115 | APX115
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorNADPH
-
Research AreaMetabolic Disease
-
IndicationDiabetes
Chemical Information
-
CAS Number1395946-75-4
-
Formula Weight315.801
-
Molecular FormulaC17H18ClN3O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (316.66 mM)
-
SMILESOC1=C(CCC)C(C2=CC=CC=C2)=NN1C3=NC=CC=C3.Cl
-
Chemical Name3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cha JJ, et al. Lab Invest. 2017 Apr;97(4):419-431.
2. Kwon G, et al. Oncotarget. 2017 Jun 16. doi: 10.18632/oncotarget.18540.
3. Joo JH, et al. Sci Rep. 2016 Mar 15;6:22389.
molnova catalog
related products
-
NoxA1ds
Potent and selective NADPH oxidase 1 (NOX1) inhibitor (IC50 = 20 nM). Exhibits selectivity for NOX1 over NOX2, NOX4, NOX5 and xanthine oxidase. Inhibits NOX1-derived O2- production in HT-29 human colon cancer cells. Attenuates VEGF-induced human pulmonary artery endothelial cell migration under hypoxic conditions in vitro. Cell permeable.
-
Quercetin-3-O-glucos...
Quercetin-3-O-glucose-6''-acetate is an inhibitor of NADPH oxidase. Quercetin-3-O-glucose-6''-acetate has antioxidant activities.
-
AKR1C3-IN-1
AKR1C3-IN-1 is a potent and selective inhibitor of AKR1C3(IC50 of 13 nM).
Cart
sales@molnova.com